Aberrant methylation of RASSF1A is associated with poor survival in Tunisian breast cancer patients
- 6 August 2009
- journal article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 136 (2) , 203-210
Abstract
Epigenetic gene silencing is one of the major causes of inactivation of tumor-suppressor genes in many human cancers. The aim of the present study was to determine the methylation status of the promoter region CpG islands of four cancer-related genes RASSF1A, RARβ2, CDH1, and p16 INK4a in 78 breast cancer specimens and to evaluate whether the methylation status is associated with estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2/neu) together with the major clinico-pathological parameters. We showed that the methylation frequencies ranged from 19.6% (p16 INK4a ) to 87% (RASSF1A) in primary breast tumors of Tunisian patients. Aberrant methylation of RARβ2 was observed in 66.6% of cases and associated with age at diagnosis (P = 0.043), while CDH1 was methylated in 47.4% of tumors and was correlated with tumor size (P = 0.013). RASSF1A presented the highest percentage of methylation (87%) and was strongly associated with poor survival (P = 0.014), with age (P = 0.048), and tumor stage (P = 0.033). Loss of ER and PR was strongly associated with GIII tumors (P = 0.000 and 0.037 respectively) while HER2/neu was associated with lymph node involvement (P = 0.026) and 5-year survival rate (P = 0.028). Our preliminary findings suggested that aberrant methylation of RASSF1A and RARβ2 occurs frequently in Tunisian breast cancer patients compared with others. Furthermore, RASSF1A hypermethylation could be used as a potential marker of poor prognosis.Keywords
This publication has 42 references indexed in Scilit:
- Clinical significance of promoter hypermethylation of RASSF1A, RARβ2, BRCA1 and HOXA5 in breast cancers of Indian patientsLife Sciences, 2008
- Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumorsBreast Cancer Research, 2008
- Evidence for a role of the Simian Virus 40 in human breast carcinomasBreast Cancer Research and Treatment, 2008
- Correlation between CpG methylation profiles and hormone receptor status in breast cancersBreast Cancer Research, 2007
- Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patientsLife Sciences, 2007
- Breast cancer risk factors according to joint estrogen receptor and progesterone receptor statusCancer Detection Prevention, 2005
- DNA methylation and breast carcinogenesisOncogene, 2002
- DNA methylation patterns and epigenetic memoryGenes & Development, 2002
- Methylation of the p16Ink4a tumor suppressor gene 5′-CpG island in breast cancerCancer Letters, 2001
- Epidemiologic features of rapidly progressing breast cancer in TunisiaCancer, 1980